<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02742870</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-MRI-Adnexal Tumor</org_study_id>
    <nct_id>NCT02742870</nct_id>
  </id_info>
  <brief_title>Diffusion MRI (Magnetic Resonance Imaging) Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness</brief_title>
  <official_title>Diffusion Magnetic Resonance Imaging Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brugmann University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diffusion-weighted sequences have been routinely performed for years to study the pelvis.
      They have been so far mainly qualitatively interpreted, that is to say as the absence or
      presence of an hypersignal at a high b value. The quantitative analysis involves placing the
      region of interest (ROI) on the apparent diffusion coefficient (ADC) map. The manual
      placement is very operator dependent, and does not reflect the entirety of the studied mass.

      In all fields of Magnetic Resonance Imaging, a multiparametric approach integrating diffusion
      analysis is flourishing. However, the quantitative analysis of the diffusion is still little
      studied for tumor heterogeneity analysis, including in the gynecological sphere.

      The investigators will therefore retrospectively evaluate the apparent diffusion coefficient
      (ADC) histograms, extracted from the diffusion ponderation sequences, of the magnetic imaging
      resonance analysis of adnexal masses and confront the results with the anatomo-pathology
      results, for patients having undergone surgery, and/or with the clinical and imagery
      follow-up results.

      The investigators goal will be to improve the performance of conventional MRI in the analysis
      of adnexal masses.

      The expected benefits of this study are:

        -  a correlation with the histology analysis or the clinical monitoring

        -  an improved prediction of the malignancy of the tumor

        -  an improved magnetic resonance imaging performance for adnexal masses, with better
           surgical therapeutic management

        -  an improved negative predictive value, thereby ultimately limiting unnecessary surgical
           explorations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Apparent diffusion coefficient (ADC) of the adnexal mass volume (mm2/sec)</measure>
    <time_frame>From 01/01/2015 till the end of study (2 years)</time_frame>
    <description>Apparent diffusion coefficient (ADC) expressed in mm2/sec. Magnetic resonance images realised with the Ingenia 3 Tesla Engine (Philips) and the Area 1,5 Tesla Engine (Siemens).Post-processing realized with the Syngo Onco Care application of Siemens.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomo-pathology classification - histological type</measure>
    <time_frame>From 01/01/2015 till the end of study (2 years)</time_frame>
    <description>Follow-up of the patients that did undergo surgery: histological type of tumor. The histological type of the tumor will be determined by the Anatomo-Pathology Department of the CHU Brugmann hospital, according to standard of care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MRI Adnex score</measure>
    <time_frame>From 01/01/2015 till the end of study (2 years)</time_frame>
    <description>Follow-up of the patients that did not undergo surgery: medical imaging classification of the adnexal mass (MRI Adnex score)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IOTA ultrasound classification</measure>
    <time_frame>From 01/01/2015 till the end of study (2 years)</time_frame>
    <description>Follow-up of the patients that did not undergo surgery: transvaginal ultrasound classification of the adnexal masse (IOTA ultrasound classification)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomo-pathology classification - malignancy grading of tumor</measure>
    <time_frame>From 01/01/2015 till the end of study (2 years)</time_frame>
    <description>Follow-up of the patients that did undergo surgery: malignancy grading of the adnexal mass according to FIGO classification.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Adnexal Tumor</condition>
  <arm_group>
    <arm_group_label>Patients with MRI pelvic imaging</arm_group_label>
    <description>Women over 18 years old, having undergone a magnetic resonance imaging of the pelvis within the CHU Brugmann Hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Correlation of MRI results with clinical characteristics of the adnexal mass</intervention_name>
    <description>Quantitative analysis of the magnetic resonance images realised with the Ingenia 3 Tesla Engine (Philips) and the Area 1,5 Tesla Engine (Siemens), based on the ADC cartography.The post-processing will be realized with the Syngo Onco Care application of Siemens, that allows an histogram analysis of the ADC of all sections of the adnexal mass, as opposed to a section per section approach with the Region of Interest (ROI) method.
The results will be correlated with the clinical data regarding the adnexal mass: anatomo-pathology status (malignancy and aggressiveness of the tumor) and the gynecological follow-up.</description>
    <arm_group_label>Patients with MRI pelvic imaging</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women having undergone magnetic resonance imaging of the pelvis within the CHU Brugmann
        hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Women aged over 18 years old, having undergone magnetic resonance imaging of the pelvis
        within the CHU Brugmann hospital.

        Exclusion Criteria:

          -  Examinations without diffusion sequences

          -  Examinations with incomplete diffusion sequences

          -  Absence of anato-pathologic result, or absence of gynecological clinical/imaging
             follow-up.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mieke Cannie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nathalie Hottat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nathalie Hottat, MD</last_name>
    <phone>003224772434</phone>
    <email>Nathalie.HOTTAT@chu-brugmann.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mieke Cannie, MD</last_name>
    <phone>003224754204</phone>
    <email>Mieke.CANNIE@chu-brugmann.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Hottat, MD</last_name>
      <phone>003224754187</phone>
      <email>Nathalie.HOTTAT@chu-brugmann.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Thomassin-Naggara I, Aubert E, Rockall A, Jalaguier-Coudray A, Rouzier R, Dara√Ø E, Bazot M. Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology. 2013 May;267(2):432-43. doi: 10.1148/radiol.13121161. Epub 2013 Mar 6.</citation>
    <PMID>23468574</PMID>
  </reference>
  <reference>
    <citation>Just N. Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer. 2014 Dec 9;111(12):2205-13. doi: 10.1038/bjc.2014.512. Epub 2014 Sep 30. Review.</citation>
    <PMID>25268373</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2016</study_first_submitted>
  <study_first_submitted_qc>April 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2016</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Mieke Cannie</investigator_full_name>
    <investigator_title>Head of clinic</investigator_title>
  </responsible_party>
  <keyword>Diffusion MRI</keyword>
  <keyword>ADC histograms</keyword>
  <keyword>Adnexal tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aggression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

